Friday, December 12, 2025 | 10:24 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

49 scientists, doctors throw their weight behind Covid-19 vaccines

The decision of Drugs Controller General of India to allow accelerated approval or the emergency use approval for Covaxin had become a contentious issue

Coronavirus, vaccine, covid, drugs, clinical trials
premium

At present, SII is conducting phase two and three trials at 15 different centres in India as bridging studies

Ruchika Chitravanshi New Delhi
Forty-nine scientists and doctors, while vouching for the safety of Bharat Biotech’s Covaxin and Serum Institute of India’s Covishield, expressed shock at the “irresponsible statements by vested interest in media...defaming scientific community”.

Just one day away from the vaccine roll-out, a statement signed by T D Dogra, former director of All India Institute of Medical Sciences on behalf of the group, said, “Such reprehensible utterances are causing huge credibility crisis for Indian scientific community who have devoted their lifetimes to make India a name to reckon with in export of vaccines all over the world.”  

The health ministry has, meanwhile,